Using data in psychiatry: From measurement to meaning

Abstract

Get full access to this article

View all access options for this article.

References

Bellagarda

Padmanabhan

Dondzilo

, et al. (2026) Temporal trends in youth mental health: Insights and predictions from 20 years of Child and Adolescent Mental Health Services data. Australian and New Zealand Journal of Psychiatry 60(5): 464–475.

Jorm

Reavley

, et al. (2026) Supportive actions towards people with mental health problems in the community: A National Survey of Australian Adults. Australian and New Zealand Journal of Psychiatry 60(5): 476–484.

Kar Ray

Dark

Kisely

, et al. (2025) The future of psychiatry: Reclaiming relevance in an era of technological and systemic transformation. Australian and New Zealand Journal of Psychiatry 60(5): 411–417.

Loi

Malpas

, et al. (2026) NUCOG10: The development and validation of a short form of the NUCOG cognitive assessment tool. Australian and New Zealand Journal of Psychiatry 60(5): 454–463.

Macauley

Bower

Webster

, et al. (2025) Health services and digital technologies used for mental health among a national cross-sectional sample of young people in Australia 2020–2022: Patterns and correlates within geographic regions. Australian and New Zealand Journal of Psychiatry 60(5): 426–442.

Maybery

Cameron

Gallo

Cordoba B

, et al. (2025) Exploring the measurement validity of the Your Experience of Service (YES) survey. Australian and New Zealand Journal of Psychiatry 60(5): 418–425.

McNamara

Mayers

Draper

, et al. (2026) Using machine learning based Natural Language Processing to quantify emergency department presentations related to suicide or self harm in the Australian Capital Territory. Australian and New Zealand Journal of Psychiatry 60(5): 443–453.

Prosser

Vidyattama

Faulkner

(2026) Psychostimulant medication for ADHD and socio economic status in Australia (2003–2022). Australian and New Zealand Journal of Psychiatry 60(5): 485–492.

Tanzer

Rutland

Warren

, et al. (2026) Smoking, plasma concentration, antipsychotic polypharmacy, and adverse drug reaction burden in clozapine outpatients. Australian and New Zealand Journal of Psychiatry 60(5): 493–505.